echoloc

MEDSIR Tech Stack

Clinical trial design and management for oncology research

Research Services Barcelona, Catalonia 51–200 employees Founded 2012 Privately Held

MEDSIR connects oncology researchers worldwide with funding sources to design and execute investigator-initiated clinical trials. The company operates a lean tech stack (Excel, CDISC, Microsoft Office, cloud storage on Azure/AWS) focused on trial logistics rather than proprietary software—a pattern typical of services-driven research orgs. Hiring velocity is accelerating across research, ops, and finance roles, while pain points cluster around patient recruitment, cost control, and regulatory compliance, suggesting operational scaling pressure as trial volume grows.

Tech Stack 12 technologies

Core StackAWS Excel CDISC PowerPoint Microsoft Office Azure SharePoint Windows macOS iOS Android

What MEDSIR Is Building

Challenges

  • Improving gross margin
  • Patient recruitment and retention
  • Controlling costs and quality of studies
  • Supporting security certifications and regulatory audits
  • Operational challenges in trials
  • Site selection and engagement
  • Managing international clinical trials
  • Project data management requirements
  • Managing public funding projects
  • Budget optimization

Active Projects

  • Vendor selection for start-up studies
  • International clinical trials eu & us
  • Public funding projects and h2020 studies
  • Strategic operational collaborations
  • Site selection and engagement
  • Patient recruitment and retention
  • Clinical study protocol development
  • Clinical data model development
  • Database build and validation
  • Vendor database maintenance

Hiring Activity

Accelerating20 roles · 15 in 30d

Department

Research
5
Ops
3
Finance
2
Healthcare
2
Engineering
1
HR
1
Marketing
1
Quality
1

Seniority

Mid
5
Intern
4
Junior
3
Senior
3
Director
2
Manager
2
Company intelligence

Find more companies like MEDSIR by tech stack, pain points and active projects

Get started free

About MEDSIR

MEDSIR is a private research services company founded in 2012 and headquartered in Barcelona. The company designs and manages clinical trials in oncology, acting as a broker between academic oncologists and pharmaceutical/biotech sponsors seeking to fund investigator-initiated research. MEDSIR supports over 200 active trial concepts spanning prostate, lung, breast, ovarian, and endometrial cancers. The company operates across the European Union and US, managing the full trial lifecycle from protocol development and site selection through patient recruitment to final publication. Revenue sources include trial sponsorship fees, vendor management, and public funding projects (H2020, European grants).

HeadquartersBarcelona, Catalonia
Company Size51–200 employees
Founded2012
Hiring MarketsSpain

Frequently Asked Questions

What technology does MEDSIR use?

MEDSIR's core stack is Excel, CDISC (Clinical Data Interchange Standards Consortium), PowerPoint, Microsoft Office, Azure, and AWS. The tooling reflects a services-led model focused on trial management and data standardization rather than custom software development.

How many clinical trials does MEDSIR manage?

MEDSIR supports over 200 active trial ideas involving innovative oncology drugs across multiple cancer types, including prostate, lung, breast, ovarian, and endometrial cancer research.

Similar Companies in Research Services

Other companies in the same industry, closest in size